National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Participation in Roadmap Trans-NIH Strategic Initiatives
    Posted: 06/30/2006



Roadmap for Medical Research






NCI's Participation in the NIH Roadmap






NIH Roadmap Transition to OPASI






Roadmap Inclusion Criteria






NCI Points of Contact



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
The Cancer Genome Atlas Reports Brain Tumors Study

NCI Research Coding and Reporting

NCI Launches Community Cancer Centers Pilot

The Nation's Investment in Cancer Research FY 2009

NCI Training and Career Development Inventory

New MERIT Award Winners Announced

caBIG: Connecting the Cancer Community

NCI Participation in the NIH Roadmap

Past Highlights
Related Pages
NIH Roadmap for Medical Research
Web site for the NIH Roadmap.

Subscribe to the NIH Roadmap E-mail List
Add your name to the NIH Roadmap Listserv to receive up-to-date information on Roadmap funding opportunities.

OPASI
NIH Office of Portfolio Analysis and Strategic Initiatives

Annual Planning and Selection Process for NIH Roadmap
NCI Participation in the Roadmap and OPASI - NCI Points of Contact

Numerous NCI staff have been actively involved in the Roadmap initiatives, providing scientific and technical expertise and staff support to many of the areas of science that align with the NCI mission. For more information about participating NCI staff, see NCI Contacts for NIH Roadmap for Medical Research.

NCI points of contact by coordinating and leadership committees:

    NIH Institute and Centers Director Meetings Related to Roadmap: Dr. John Niederhuber, Director, NCI;

    Roadmap Institute and Center Liaison (RICL) Committee: Dr. Dinah Singer, Director, NCI Division of Cancer Biology and Ms. Anne Tatem, NCI Roadmap Coordinator, DCB

    OPASI Working Group (OPASI WG): Dr. Robert Croyle, Director, Division of Cancer Control and Population Sciences

Questions: Contact Anne Tatem tatema@mail.nih.gov.

< Previous Section


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov